EGFR and neoplasm: found that high EGFR expression drives tumor proliferation and is associated with poor prognosis.[38] These findings suggest that breast cancer and renal cell carcinoma may share certain key proliferation signaling pathways, providing insights for cross‐cancer molecular mechanism studies.